A pharmaceutical preparation that may be used for the prevention or treatment of allergens against Alternaria and / or Cladosporium fungi, a pharmaceutically acceptable carrier or diluent, and at least three selected from the following: Pharmaceutical preparation containing peptide or pharmaceutically acceptable salt thereof: (a) polypeptide comprising amino acid sequence WSWKIGPAIATGNT (Alt28； SEQ ID NO: 101) or a T cell epitope-containing variant sequence derived from the amino acid sequence, or a salt thereof (b) Amino acid sequence KYRRVVRAGVKVAQTAR (Alt34A； SEQ ID NO: 107) or a polypeptide comprising a T cell epitope-containing mutant sequence derived from the amino acid sequence, or a salt thereof； (c) Amino acid sequence KYAGVFVSTGTLGGG (SEQ ID NO: 112 ) Or a polypeptide comprising a T cell epitope-containing variant sequence derived from the amino acid sequence, or a salt thereof； (d) amino acid sequence AEVYQKLKALAKKTYGQ (Alt13A； SEQ ID NO: 83) or A polypeptide comprising a T-cell epitope-containing variant sequence derived from an amino acid sequence, or a salt thereof； (e) comprising an amino acid sequence SLGFNIKATNGGTLD (Alt01A； SEQ ID NO: 60) or a T-cell epitope-containing variant sequence derived from the amino acid sequence (F) Amino acid sequence SAKRMKVAFKLDIEK (Alt06； SEQ ID NO: 72) or a polypeptide comprising a T cell epitope-containing mutant sequence derived from the amino acid sequence, or a salt thereof； (g) amino acid sequence DITYVATATLPNYCR (SEQ ID NO: 111) or a polypeptide comprising a T cell epitope-containing variant sequence derived from the amino acid sequence, or a salt thereof； and (h) the amino acid sequence GWGVMVSHRSGET (Alt14； SEQ ID NO: 84) or the amino acid sequence A polypeptide comprising a T cell epitope-containing variant sequence, or a salt thereof； wherein the T cell epitope-containing variant sequence of the amino acid sequence comprises up to 7 amino acid modifications An amino acid sequence having, each modification i
